Alan Fosnacht Name match only — unverified

Consultant · activity score 21

21 IND-paid disbursements
$59,288
paid as individual · 1 payer
2y
activity span (2024-2025)

Activity over time 2 year span

2024: 0 committee · 0 candidate · 20 IND-paid ($56K)20242025: 0 committee · 0 candidate · 1 IND-paid ($3K)2025
Committee-officer role Candidate filing IND-paid disbursement

Top payers 1 committee · $59,288 total

Committee Payments Total
MARLINGA FOR CONGRESS 21 $59,288

Aggregated across all Schedule B IND payments to this name. Color: derived partisan lean of the paying committee (direct party_affiliation OR committee_partisan_lean.lean_score for super PACs).

Recent payments to this name last 20 · $58,974

DatePayerPurposeAmount
Jan 14, 2025 MARLINGA FOR CONGRESS WAGES $3,141
Dec 30, 2024 MARLINGA FOR CONGRESS WAGES $3,136
Dec 12, 2024 MARLINGA FOR CONGRESS WAGES $3,136
Dec 6, 2024 MARLINGA FOR CONGRESS WAGES $1,500
Nov 27, 2024 MARLINGA FOR CONGRESS WAGES $3,136
Nov 22, 2024 MARLINGA FOR CONGRESS WAGES $1,176
Nov 14, 2024 MARLINGA FOR CONGRESS WAGES $3,136
Oct 31, 2024 MARLINGA FOR CONGRESS WAGES $3,136
Oct 15, 2024 MARLINGA FOR CONGRESS WAGES $3,136
Sep 30, 2024 MARLINGA FOR CONGRESS WAGES $3,136
Sep 12, 2024 MARLINGA FOR CONGRESS WAGES $3,265
Aug 29, 2024 MARLINGA FOR CONGRESS WAGES $3,265
Aug 14, 2024 MARLINGA FOR CONGRESS WAGES $3,265
Jul 31, 2024 MARLINGA FOR CONGRESS WAGES $3,265
Jul 15, 2024 MARLINGA FOR CONGRESS WAGES $3,265
Jun 28, 2024 MARLINGA FOR CONGRESS WAGES $3,265
Jun 14, 2024 MARLINGA FOR CONGRESS WAGES $3,550
May 30, 2024 MARLINGA FOR CONGRESS WAGES $3,549
May 14, 2024 MARLINGA FOR CONGRESS WAGES $3,094
May 13, 2024 MARLINGA FOR CONGRESS INSURANCE $1,422

Disbursement rows where this name appears as the payee (schedule_b entity_tp='IND'). Name-matched, not identity-resolved — may include same-named individuals.

Geographic concentration 1 state

MI
1 payer cmte

Composite of candidate filings (cand.state) + states of distinct payer committees. Surfaces where the operative is geographically active.